PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vitamin B12 supplements may help treat hepatitis C

Safe and inexpensive option for boosting response rate to antiviral drugs

2012-07-18
(Press-News.org) Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.

The effects were particularly strong in patients whose infection was proving difficult to treat effectively, the findings showed.

Between 60% and 80% of those infected with the viral liver infection HCV will go on to develop chronic hepatitis, and roughly a third of them will progress to cirrhosis and terminal liver disease.

Standard treatment of interferon (peg IFN) and ribavarin clears the virus in about 50% of patients infected with genotype 1 HCV and 80% of those infected with genotypes 2 or 3.

But this approach fails to clear the virus in around half of all those infected with HCV or the infection returns once treatment stops.

While trials of new generation antiviral drugs show promise, they are expensive, and can make treatment more difficult. And questions still remain about how well they will work in practice, say the authors.

Experimental research dating back a decade suggests that vitamin B12 may have a role in suppressing HCV. The liver is the body's primary storage centre for vitamin B12, but this capacity is impaired by diseases directly affecting the organ.

The researchers therefore wanted to see if adding vitamin B12 to standard treatment would make a difference.

Ninety four patients with HCV infection were randomly allocated to receive standard treatment or standard treatment plus vitamin B12 (5000 ug every 4 weeks) for between 24 (genotypes 2 and 3) and 48 weeks (genotype 1).

The body's ability to clear the virus was assessed after 4 weeks (rapid viral response), after 12 weeks (complete early viral response), at the end of treatment and at 24 weeks after stopping treatment (sustained viral response).

There was no difference between the two treatment approaches at 4 weeks, but there were significant differences in response at all the other time points, particularly 24 weeks after stopping treatment, which is the aim of HCV treatment and the closest it can be get to a cure.

The effects were also significantly greater among those who carried the type 1 strain, which is particularly hard to treat, and those high levels of infection (high viral load) to begin with.

Overall, adding vitamin B12 to standard therapy strengthened the rate of sustained viral response by 34%, the findings showed.

The authors conclude that until clear eligibility criteria for treatment with the new generation antiviral drugs are established, standard treatment plus vitamin B12 is a safe and inexpensive alternative, particularly for those who carry a strain of the virus that is hard to treat.

They add: "This strategy would be especially useful in those countries where, owing to limited economic means, the new generation antiviral therapies cannot be given in routine practice."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Man-made pores mimic important features of natural pores

2012-07-18
BUFFALO, N.Y. -- Inspired by nature, an international research team has created synthetic pores that mimic the activity of cellular ion channels, which play a vital role in human health by severely restricting the types of materials allowed to enter cells. The pores the scientists built are permeable to potassium ions and water, but not to other ions such as sodium and lithium ions. This kind of extreme selectivity, while prominent in nature, is unprecedented for a synthetic structure, said University at Buffalo chemistry professor Bing Gong, PhD, who led the study. The ...

Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research

2012-07-18
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapsing‑remitting form of the disease. The study, led by Drs. Helen Tremlett, Afsaneh Shirani, Joel Oger and others, shows no strong evidence that a group of drugs, beta interferons (β-IFNs), prescribed to treat MS had a measurable ...

New video series highlights the people who fuel America's innovation pipeline

2012-07-18
The researchers reflect on their work as well as how the U.S. system for funding research makes the United States a leader. "Because of the opportunities provided by federal research funding, we are developing a generation of scientists that has no competitor on planet Earth," says Erik Dutson, executive medical director of the Center for Advanced Surgical and Interventional Technology at the University of California, Los Angeles. They also talk about the risks of decreased funding. "If you have a population of scientists that [don't] have the resources to train the ...

Girls with eating disorders regain healthy fatty acid levels when their weight normalizes

2012-07-18
A study of teenage girls with eating disorders has shown that reduced essential fatty acid levels returned to normal once the girls increased their weight to a healthy level. The research, published in the August issue of Acta Paediatrica, suggests that it is not necessary to give omega-3 polyunsaturated fatty acid supplements to adolescent girls with eating disorders. "Essential fatty acid status is altered in eating disorders that result in weight loss" explains co-author Dr Ingemar Swenne from Uppsala University Children's Hospital. "This is important because ...

Scientists find new way to induce programmed cell death, or apoptosis

2012-07-18
Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have developed a technique to cause apoptosis, or programmed cell death, that could lead to new approaches to treating cancer. Apoptosis is an essential defense mechanism against the spread of abnormal cells such as cancer. It is a complex process that occurs through networks of proteins that interact with each other. Cancer cells usually avoid this process due to mutations in the genes that encode the relevant proteins. The result is that the cancer cells survive and take over while ...

What it takes to be the perfect invading parasite

2012-07-18
Scientists from the Zoological Society of London (ZSL) are the first to document the characteristics of invading parasites, using malaria in New Zealand bird species. The study, published today in Ecology Letters, identifies the factors influencing the success of parasites unintentionally introduced to new environments. Avian malaria is a disease caused by species of parasites, of the genus Plasmodium, which infects birds. Just like human malaria, it is spread by mosquitoes, and the parasites spend part of their lives in red blood cells of birds. Avian malaria is common ...

In search of the key word

2012-07-18
Human beings have the ability to convert complex phenomena into a one-dimensional sequence of letters and put it down in writing. In this process, keywords serve to convey the content of the text. How letters and words correlate with the subject of a text is something Eduardo Altmann and his colleagues from the Max Planck Institute for the Physics of Complex Systems have studied with the help of statistical methods. They discovered that what denotes keywords is not the fact that they appear very frequently in a given text. It is that they are found in greater numbers only ...

Marijuana use doubles risk of premature birth

2012-07-18
A large international study led by University of Adelaide researchers has found that women who use marijuana can more than double the risk of giving birth to a baby prematurely. Preterm or premature birth - at least three weeks before a baby's due date - can result in serious and life-threatening health problems for the baby, and an increased risk of health problems in later life, such as heart disease and diabetes. A study of more than 3000 pregnant women in Adelaide, Australia and Auckland, New Zealand has detailed the most common risk factors for preterm birth. ...

Infants' recognition of speech more sophisticated than previously known, NYU researchers find

2012-07-18
The ability of infants to recognize speech is more sophisticated than previously known, researchers in New York University's Department of Psychology have found. Their study, which appears in the journal Developmental Psychology, showed that infants, as early as nine months old, could make distinctions between speech and non-speech sounds in both humans and animals. "Our results show that infant speech perception is resilient and flexible," explained Athena Vouloumanos, an assistant professor at NYU and the study's lead author. "This means that our recognition of speech ...

Marriage has different meanings for blacks and whites

2012-07-18
EAST LANSING, Mich. — Black people who are married don't appear to live any longer than black couples who simply live together, suggesting marriage doesn't boost longevity for blacks the way it does for whites, according to a large national study led by Michigan State University. "This finding implies that marriage and cohabitation have very different meanings for blacks and whites," said MSU sociologist Hui Liu, the study's lead researcher. The study, in the Journal of Marriage and Family, is the first to document mortality differences between cohabiters and married ...

LAST 30 PRESS RELEASES:

AI can spot which patients need treatment to prevent vision loss in young adults

Half of people stop taking popular weight-loss drug within a year, national study finds

Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds

Smoking increases the risk of type 2 diabetes, regardless of its characteristics

Scientists trace origins of now extinct plant population from volcanically active Nishinoshima

AI algorithm based on routine mammogram + age can predict women’s major cardiovascular disease risk

New hurdle seen to prostate screening: primary-care docs

MSU researchers explore how virtual sports aid mental health

Working together, cells extend their senses

Cheese fungi help unlock secrets of evolution

Researchers find brain region that fuels compulsive drinking

Mental health effects of exposure to firearm violence persist long after direct exposure

Research identifies immune response that controls Oropouche infection and prevents neurological damage

University of Cincinnati, Kent State University awarded $3M by NSF to share research resources

Ancient DNA reveals deeply complex Mastodon family and repeated migrations driven by climate change

Measuring the quantum W state

Researchers find a way to use antibodies to direct T cells to kill Cytomegalovirus-infected cells

Engineers create mini microscope for real-time brain imaging

Funding for training and research in biological complexity

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: September 12, 2025

ISSCR statement on the scientific and therapeutic value of human fetal tissue research

Novel PET tracer detects synaptic changes in spinal cord and brain after spinal cord injury

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Benchmark study tracks trends in dog behavior

OpenAI, DeepSeek, and Google vary widely in identifying hate speech

Research spotlight: Study identifies a surprising new treatment target for chronic limb threatening ischemia

Childhood loneliness and cognitive decline and dementia risk in middle-aged and older adults

Parental diseases of despair and suicidal events in their children

Acupuncture for chronic low back pain in older adults

Acupuncture treatment improves disabling effects of chronic low back pain in older adults

[Press-News.org] Vitamin B12 supplements may help treat hepatitis C
Safe and inexpensive option for boosting response rate to antiviral drugs